Glypican-3 deficiency in liver cancer upregulates MAPK/ERK pathway but decreases cell proliferation is a research paper published in American Journal of Cancer Research (2024). On theSindex it has a DataRank of 0. It has been cited 12 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Intramural NIH HHS
Grant: ZIA BC011800
Intramural NIH HHS
Grant: ZIA BC010891
National Institutes of Health
Grant: 1ZIABC010891-15
Development of new antibody-based cancer therapies
FWCI
1.93
Citation Percentile
0.9%
Citation Trend
Fields of Study
Keywords